Literature DB >> 12819050

Linear and circular plasmid content in Borrelia burgdorferi clinical isolates.

Radha Iyer1, Ogori Kalu, Joye Purser, Steven Norris, Brian Stevenson, Ira Schwartz.   

Abstract

The genome of Borrelia burgdorferi, the etiologic agent of Lyme disease, is composed of a linear chromosome and more than 20 linear and circular plasmids. Typically, plasmid content analysis has been carried out by pulsed-field gel electrophoresis and confirmed by Southern hybridization. However, multiple plasmids of virtually identical sizes (e.g., lp28 and cp32) complicate the interpretation of such data. The present study was undertaken to investigate the complete plasmid complements of B. burgdorferi clinical isolates cultivated from patients from a single region where early Lyme disease is endemic. A total of 21 isolates obtained from the skin biopsy or blood samples of Lyme disease patients were examined for their complete plasmid complements by Southern hybridization and plasmid-specific PCR analysis. All clinical isolates harbored at least six of the nine previously characterized cp32s. Fourteen isolates harbored all B31-like linear plasmids, and seven isolates simultaneously lacked lp56, lp38, and some segments of lp28-1. The distinctive plasmid profile observed in these seven isolates was specific to organisms that had ribosomal spacer type 2 and pulsed-field gel type A, which implies a clonal origin for this genotype. The presence of nearly identical complements of multiple linear and circular plasmids in all of the human isolates suggests that these plasmids may be particularly necessary for infection, adaptation, and/or maintenance in the infected host.

Entities:  

Mesh:

Year:  2003        PMID: 12819050      PMCID: PMC161973          DOI: 10.1128/IAI.71.7.3699-3706.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  71 in total

1.  Molecular and evolutionary analysis of Borrelia burgdorferi 297 circular plasmid-encoded lipoproteins with OspE- and OspF-like leader peptides.

Authors:  D R Akins; M J Caimano; X Yang; F Cerna; M V Norgard; J D Radolf
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

2.  Linear- and circular-plasmid copy numbers in Borrelia burgdorferi.

Authors:  J Hinnebusch; A G Barbour
Journal:  J Bacteriol       Date:  1992-08       Impact factor: 3.490

3.  Stability of erp loci during Borrelia burgdorferi infection: recombination is not required for chronic infection of immunocompetent mice.

Authors:  N El Hage; L D Lieto; B Stevenson
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

4.  Cloning and molecular characterization of a multicopy, linear plasmid-carried, repeat motif-containing gene from Borrelia turicatae, a causative agent of relapsing fever.

Authors:  J A Carlyon; R T Marconi
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

5.  Longitudinal study of infection with Borrelia burgdorferi in a population of Peromyscus leucopus at a Lyme disease-enzootic site in Maryland.

Authors:  E K Hofmeister; B A Ellis; G E Glass; J E Childs
Journal:  Am J Trop Med Hyg       Date:  1999-04       Impact factor: 2.345

6.  Genetic diversity of Borrelia burgdorferi in lyme disease patients as determined by culture versus direct PCR with clinical specimens.

Authors:  D Liveris; S Varde; R Iyer; S Koenig; S Bittker; D Cooper; D McKenna; J Nowakowski; R B Nadelman; G P Wormser; I Schwartz
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto.

Authors:  I N Wang; D E Dykhuizen; W Qiu; J J Dunn; E M Bosler; B J Luft
Journal:  Genetics       Date:  1999-01       Impact factor: 4.562

8.  Evidence of past recombination events among the genes encoding the Erp antigens of Borrelia burgdorferi.

Authors:  Brian Stevenson; Sherwood Casjens; Patricia Rosa
Journal:  Microbiology (Reading)       Date:  1998-07       Impact factor: 2.777

9.  Low-passage-associated proteins of Borrelia burgdorferi B31: characterization and molecular cloning of OspD, a surface-exposed, plasmid-encoded lipoprotein.

Authors:  S J Norris; C J Carter; J K Howell; A G Barbour
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

10.  Diagnosis of early Lyme disease by polymerase chain reaction amplification and culture of skin biopsies from erythema migrans lesions.

Authors:  I Schwartz; G P Wormser; J J Schwartz; D Cooper; P Weissensee; A Gazumyan; E Zimmermann; N S Goldberg; S Bittker; G L Campbell; C S Pavia
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

View more
  48 in total

1.  Functional analysis of Borrelia burgdorferi uvrA in DNA damage protection.

Authors:  Mariya Sambir; Larisa B Ivanova; Anton V Bryksin; Henry P Godfrey; Felipe C Cabello
Journal:  FEMS Microbiol Lett       Date:  2011-02-17       Impact factor: 2.742

2.  Bgp, a secreted glycosaminoglycan-binding protein of Borrelia burgdorferi strain N40, displays nucleosidase activity and is not essential for infection of immunodeficient mice.

Authors:  Nikhat Parveen; Kenneth A Cornell; James L Bono; Christen Chamberland; Patricia Rosa; John M Leong
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

3.  The OspE-related proteins inhibit complement deposition and enhance serum resistance of Borrelia burgdorferi, the lyme disease spirochete.

Authors:  Melisha R Kenedy; Darrin R Akins
Journal:  Infect Immun       Date:  2011-01-31       Impact factor: 3.441

4.  Rrp1, a cyclic-di-GMP-producing response regulator, is an important regulator of Borrelia burgdorferi core cellular functions.

Authors:  Elizabeth A Rogers; Darya Terekhova; Hong-Ming Zhang; Kelley M Hovis; Ira Schwartz; Richard T Marconi
Journal:  Mol Microbiol       Date:  2009-01-23       Impact factor: 3.501

5.  Borrelia burgdorferi linear plasmid 38 is dispensable for completion of the mouse-tick infectious cycle.

Authors:  Daniel P Dulebohn; Aaron Bestor; Ryan O M Rego; Philip E Stewart; Patricia A Rosa
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

6.  Borrelia burgdorferi rel is responsible for generation of guanosine-3'-diphosphate-5'-triphosphate and growth control.

Authors:  Julia V Bugrysheva; Anton V Bryksin; Henry P Godfrey; Felipe C Cabello
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Experimental assessment of the roles of linear plasmids lp25 and lp28-1 of Borrelia burgdorferi throughout the infectious cycle.

Authors:  Dorothee Grimm; Christian H Eggers; Melissa J Caimano; Kit Tilly; Philip E Stewart; Abdallah F Elias; Justin D Radolf; Patricia A Rosa
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

8.  Quantitative analysis of Borrelia burgdorferi gene expression in naturally (tick) infected mouse strains.

Authors:  Sharon Lederer; Christiane Brenner; Thomas Stehle; Lise Gern; Reinhard Wallich; Markus M Simon
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

9.  Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.

Authors:  Elizabeth A Rogers; Shane V Abdunnur; John V McDowell; Richard T Marconi
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441

10.  The failure of immune response evasion by linear plasmid 28-1-deficient Borrelia burgdorferi is attributable to persistent expression of an outer surface protein.

Authors:  Monica E Embers; Xavier Alvarez; Tara Ooms; Mario T Philipp
Journal:  Infect Immun       Date:  2008-07-14       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.